MedPath

ERYTHROMYCIN

Approved
Approval ID

e3e27c8f-64d5-4e6e-bb2d-5dd3a2e3daa1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 2, 2011

Manufacturers
FDA

Stat Rx USA

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ERYTHROMYCIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-088
Application NumberANDA062746
Product Classification
M
Marketing Category
C73584
G
Generic Name
ERYTHROMYCIN
Product Specifications
Route of AdministrationORAL
Effective DateOctober 27, 2009
FDA Product Classification

INGREDIENTS (9)

ERYTHROMYCINActive
Quantity: 250 mg in 1 1
Code: 63937KV33D
Classification: ACTIB
D&C RED NO. 30Inactive
Code: 2S42T2808B
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
FD&C RED NO. 3Inactive
Code: PN2ZH5LOQY
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ERYTHROMYCIN - FDA Drug Approval Details